These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22435276)

  • 61. The Anesthetic Strategy for Patients with Mucopolysaccharidoses: A Retrospective Cohort Study.
    Lao HC; Lin YC; Liang ML; Yang YW; Huang YH; Chan YL; Hsu YW; Lin SP; Chuang CK; Cheng JK; Lin HY
    J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013292
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnosis of the mucopolysaccharidoses.
    Lehman TJ; Miller N; Norquist B; Underhill L; Keutzer J
    Rheumatology (Oxford); 2011 Dec; 50 Suppl 5():v41-8. PubMed ID: 22210670
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses.
    Barone R; Pellico A; Pittalà A; Gasperini S
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):121. PubMed ID: 30442188
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Global functional management of mucopolysaccharidoses].
    Boulay C; Lemoine M; Chabrol B
    Arch Pediatr; 2014 Jun; 21 Suppl 1():S46-9. PubMed ID: 25063385
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The mucopolysaccharidoses: a success of molecular medicine.
    Clarke LA
    Expert Rev Mol Med; 2008 Jan; 10():e1. PubMed ID: 18201392
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Surgical management of neurological manifestations of mucopolysaccharidosis disorders.
    Alden TD; Amartino H; Dalla Corte A; Lampe C; Harmatz PR; Vedolin L
    Mol Genet Metab; 2017 Dec; 122S():41-48. PubMed ID: 29153846
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Challenging symptoms in children with rare life-limiting conditions: findings from a prospective diary and interview study with families.
    Malcolm C; Hain R; Gibson F; Adams S; Anderson G; Forbat L
    Acta Paediatr; 2012 Sep; 101(9):985-92. PubMed ID: 22452449
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recommendations for Evaluation and Management of Pain in Patients With Mucopolysaccharidosis in Latin America.
    Politei JM; Gordillo-González G; Guelbert NB; de Souza CFM; Lourenço CM; Solano ML; Junqueira MM; Magalhães TSPC; Martins AM
    J Pain Symptom Manage; 2018 Jul; 56(1):146-152. PubMed ID: 29649527
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gene therapy for Mucopolysaccharidoses.
    Sawamoto K; Chen HH; Alméciga-Díaz CJ; Mason RW; Tomatsu S
    Mol Genet Metab; 2018 Feb; 123(2):59-68. PubMed ID: 29295764
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS.
    Byers S; Rozaklis T; Brumfield LK; Ranieri E; Hopwood JJ
    Mol Genet Metab; 1998 Dec; 65(4):282-90. PubMed ID: 9889015
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An update on ocular involvement in mucopolysaccharidoses.
    Ganesh A; Bruwer Z; Al-Thihli K
    Curr Opin Ophthalmol; 2013 Sep; 24(5):379-88. PubMed ID: 23872816
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The mucopolysaccharidoses and mucolipidoses.
    Kelly TE
    Clin Orthop Relat Res; 1976; (114):116-33. PubMed ID: 131015
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Orthopaedic aspects of mucopolysaccharidoses.
    White KK
    Rheumatology (Oxford); 2011 Dec; 50 Suppl 5():v26-33. PubMed ID: 22210667
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Polysomnographic characteristics in patients with mucopolysaccharidoses.
    Lin HY; Chen MR; Lin CC; Chen CP; Lin DS; Chuang CK; Niu DM; Chang JH; Lee HC; Lin SP
    Pediatr Pulmonol; 2010 Dec; 45(12):1205-12. PubMed ID: 20717914
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The ocular features of the mucopolysaccharidoses.
    Ashworth JL; Biswas S; Wraith E; Lloyd IC
    Eye (Lond); 2006 May; 20(5):553-63. PubMed ID: 15905869
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Musculoskeletal manifestations of lysosomal storage disorders.
    Aldenhoven M; Sakkers RJ; Boelens J; de Koning TJ; Wulffraat NM
    Ann Rheum Dis; 2009 Nov; 68(11):1659-65. PubMed ID: 19822711
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quantitative neuroimaging in mucopolysaccharidoses clinical trials.
    Nestrasil I; Vedolin L
    Mol Genet Metab; 2017 Dec; 122S():17-24. PubMed ID: 29111092
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management.
    Kirkpatrick K; Ellwood J; Walker RW
    Paediatr Anaesth; 2012 Aug; 22(8):745-51. PubMed ID: 22672476
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mucopolysaccharidoses and anaesthetic risks.
    Sjøgren P; Pedersen T; Steinmetz H
    Acta Anaesthesiol Scand; 1987 Apr; 31(3):214-8. PubMed ID: 3107330
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The utility of two dimensional electrophoresis in diagnosis of mucopolysaccharidosis disorders.
    Kadali S; Patlolla RD; Kolusu A; Undamatla KT; Gummadi MR; Undamatla J
    Clin Chim Acta; 2016 Jun; 457():36-40. PubMed ID: 26995660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.